BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu Z, Xiao Z, Shuai X, Tian J. Local delivery of sunitinib and Ce6 via redox-responsive zwitterionic hydrogels effectively prevents osteosarcoma recurrence. J Mater Chem B 2020;8:6418-28. [DOI: 10.1039/d0tb00970a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiu R, Sun D, Bai Y, Li J, Wang L. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma. Drug Deliv 2020;27:1704-17. [PMID: 33305647 DOI: 10.1080/10717544.2020.1856221] [Reference Citation Analysis]
2 Tan B, Tang Q, Zhong Y, Wei Y, He L, Wu Y, Wu J, Liao J. Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration. Int J Oral Sci 2021;13:9. [PMID: 33727527 DOI: 10.1038/s41368-021-00113-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]